Medfield Diagnostics AB

XSAT:MEDF (Sweden)  
kr 0.18 (0%) Jun 18
At Loss
P/B:
0.20
Market Cap:
kr 14.12M ($ 1.39M)
Enterprise V:
kr 7.01M ($ 689.00K)
Volume:
-
Avg Vol (2M):
-
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Medfield Diagnostics AB ( ) from 2012 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Medfield Diagnostics AB stock (XSAT:MEDF) PE ratio as of Sep 21 2024 is 0. More Details

Medfield Diagnostics AB (XSAT:MEDF) PE Ratio (TTM) Chart

To

Medfield Diagnostics AB (XSAT:MEDF) PE Ratio (TTM) Historical Data

Total 1226
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Medfield Diagnostics AB PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-21 At Loss 2024-04-12 At Loss
2024-06-18 At Loss 2024-04-11 At Loss
2024-06-17 At Loss 2024-04-10 At Loss
2024-06-14 At Loss 2024-04-09 At Loss
2024-06-13 At Loss 2024-04-08 At Loss
2024-06-12 At Loss 2024-04-05 At Loss
2024-06-11 At Loss 2024-04-04 At Loss
2024-06-10 At Loss 2024-04-03 At Loss
2024-06-07 At Loss 2024-04-02 At Loss
2024-06-05 At Loss 2024-03-28 At Loss
2024-06-04 At Loss 2024-03-27 At Loss
2024-06-03 At Loss 2024-03-26 At Loss
2024-05-31 At Loss 2024-03-25 At Loss
2024-05-30 At Loss 2024-03-22 At Loss
2024-05-29 At Loss 2024-03-21 At Loss
2024-05-28 At Loss 2024-03-20 At Loss
2024-05-27 At Loss 2024-03-19 At Loss
2024-05-24 At Loss 2024-03-18 At Loss
2024-05-23 At Loss 2024-03-15 At Loss
2024-05-22 At Loss 2024-03-14 At Loss
2024-05-21 At Loss 2024-03-13 At Loss
2024-05-20 At Loss 2024-03-12 At Loss
2024-05-17 At Loss 2024-03-11 At Loss
2024-05-16 At Loss 2024-03-08 At Loss
2024-05-15 At Loss 2024-03-07 At Loss
2024-05-14 At Loss 2024-03-06 At Loss
2024-05-13 At Loss 2024-03-05 At Loss
2024-05-10 At Loss 2024-03-04 At Loss
2024-05-08 At Loss 2024-03-01 At Loss
2024-05-07 At Loss 2024-02-29 At Loss
2024-05-06 At Loss 2024-02-28 At Loss
2024-05-03 At Loss 2024-02-27 At Loss
2024-05-02 At Loss 2024-02-26 At Loss
2024-04-30 At Loss 2024-02-23 At Loss
2024-04-29 At Loss 2024-02-22 At Loss
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-16 At Loss
2024-04-22 At Loss 2024-02-15 At Loss
2024-04-19 At Loss 2024-02-14 At Loss
2024-04-18 At Loss 2024-02-13 At Loss
2024-04-17 At Loss 2024-02-12 At Loss
2024-04-16 At Loss 2024-02-09 At Loss
2024-04-15 At Loss 2024-02-08 At Loss

Medfield Diagnostics AB (XSAT:MEDF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Medfield Diagnostics AB develops, markets and sells diagnostic instrumentation based on microwave technology. The company researches the use of microwave technology in stroke diagnostics. Its products consist of Strokefinder and Impending Applications.